While the anti-adipogenic, anti-inflammatory and antioxidant effects of EGCG in obesity models are well documented, our study provides new evidence that these effects may be mediated through the GREM1-BMP4 axis [43]. This evidence concerns the gene GREM1 and obesity due to melanocortin 4 receptor deficiency.